Want to see SMMNY full AI Analyst Report?
Siemens Healthineers AG Unsponsored ADR (SMMNY) Ratios
Siemens Healthineers AG Unsponsored ADR Ratios
SMMNY's free cash flow for Q3 2026 was $1.02B. For the 2026 fiscal year, SMMNY's free cash flow was decreased by $-210.00M and operating cash flow was $1.23B. See a summary of the company’s cash flow.
| Ratios | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.11 | 1.25 | 1.05 | 1.11 | 1.07 |
| Quick Ratio | 0.84 | 0.89 | 0.73 | 0.78 | 0.75 |
| Cash Ratio | 0.15 | 0.23 | 0.12 | 0.12 | 0.13 |
| Solvency Ratio | 0.11 | 0.11 | 0.11 | 0.12 | 0.11 |
| Operating Cash Flow Ratio | 0.20 | 0.21 | 0.13 | 0.19 | 0.28 |
| Short-Term Operating Cash Flow Coverage | 0.66 | 0.90 | 0.41 | 0.79 | 1.29 |
| Net Current Asset Value | $ -14.31B | $ -13.36B | $ -14.41B | $ -15.82B | $ -15.09B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.34 | 0.35 | 0.36 | 0.34 | 0.34 |
| Debt-to-Equity Ratio | 0.83 | 0.89 | 0.92 | 0.84 | 0.89 |
| Debt-to-Capital Ratio | 0.46 | 0.47 | 0.48 | 0.46 | 0.47 |
| Long-Term Debt-to-Capital Ratio | 0.38 | 0.42 | 0.40 | 0.40 | 0.42 |
| Financial Leverage Ratio | 2.46 | 2.53 | 2.58 | 2.47 | 2.61 |
| Debt Service Coverage Ratio | 0.77 | 1.13 | 0.72 | 1.19 | 1.28 |
| Interest Coverage Ratio | 8.08 | 6.93 | 8.24 | 25.97 | 33.46 |
| Debt to Market Cap | 0.33 | 0.26 | 0.30 | 0.33 | 0.22 |
| Interest Debt Per Share | 8.08 | 7.47 | 7.57 | 7.47 | 6.55 |
| Net Debt to EBITDA | 3.59 | 3.20 | 3.97 | 3.57 | 3.69 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.63% | 37.87% | 35.56% | 37.47% | 38.63% |
| EBIT Margin | 14.07% | 13.42% | 10.24% | 13.43% | 13.79% |
| EBITDA Margin | 19.61% | 18.89% | 17.43% | 19.61% | 19.56% |
| Operating Profit Margin | 14.70% | 14.76% | 11.25% | 14.11% | 15.43% |
| Pretax Profit Margin | 12.20% | 11.28% | 8.89% | 12.89% | 13.36% |
| Net Profit Margin | 9.17% | 8.68% | 6.96% | 9.39% | 9.60% |
| Continuous Operations Profit Margin | 9.28% | 8.76% | 7.03% | 9.46% | 9.70% |
| Net Income Per EBT | 75.16% | 76.97% | 78.27% | 72.79% | 71.84% |
| EBT Per EBIT | 83.05% | 76.45% | 79.02% | 91.38% | 86.57% |
| Return on Assets (ROA) | 3.88% | 4.22% | 3.23% | 4.15% | 4.12% |
| Return on Equity (ROE) | 9.53% | 10.67% | 8.35% | 10.27% | 10.77% |
| Return on Capital Employed (ROCE) | 8.69% | 9.57% | 7.34% | 8.27% | 8.73% |
| Return on Invested Capital (ROIC) | 5.88% | 6.88% | 5.13% | 5.64% | 5.94% |
| Return on Tangible Assets | 8.29% | 9.10% | 7.24% | 9.58% | 10.53% |
| Earnings Yield | 3.91% | 3.23% | 2.81% | 4.13% | 2.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.58 | 3.10 | 2.90 | 3.07 | 2.99 |
| Payables Turnover | 5.01 | 6.54 | 6.34 | 5.86 | 5.75 |
| Inventory Turnover | 3.31 | 3.32 | 3.25 | 3.39 | 3.47 |
| Fixed Asset Turnover | 4.67 | 5.00 | 5.15 | 5.08 | 4.85 |
| Asset Turnover | 0.42 | 0.49 | 0.46 | 0.44 | 0.43 |
| Working Capital Turnover Ratio | 9.62 | 12.54 | 21.14 | 21.46 | 9.87 |
| Cash Conversion Cycle | 178.89 | 171.53 | 180.63 | 164.28 | 163.54 |
| Days of Sales Outstanding | 141.41 | 117.60 | 126.00 | 118.74 | 121.93 |
| Days of Inventory Outstanding | 110.30 | 109.78 | 112.18 | 107.78 | 105.09 |
| Days of Payables Outstanding | 72.83 | 55.85 | 57.55 | 62.24 | 63.48 |
| Operating Cycle | 251.72 | 227.37 | 238.18 | 226.52 | 227.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.30 | 1.11 | 0.81 | 1.00 | 1.27 |
| Free Cash Flow Per Share | 0.95 | 0.79 | 0.43 | 0.63 | 0.96 |
| Dividend Paid and CapEx Coverage Ratio | 1.64 | 1.40 | 0.95 | 1.25 | 1.82 |
| Capital Expenditure Coverage Ratio | 3.77 | 3.55 | 2.16 | 2.65 | 4.13 |
| Operating Cash Flow Coverage Ratio | 0.16 | 0.15 | 0.11 | 0.14 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.11 | 0.08 | 0.10 | 0.15 |
| Free Cash Flow Yield | 4.13% | 2.95% | 1.81% | 2.85% | 3.42% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 25.62 | 30.93 | 35.53 | 24.20 | 35.76 |
| Price-to-Sales (P/S) Ratio | 2.34 | 2.69 | 2.47 | 2.27 | 3.43 |
| Price-to-Book (P/B) Ratio | 2.44 | 3.30 | 2.97 | 2.49 | 3.85 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.19 | 33.88 | 55.22 | 35.13 | 29.28 |
| Price-to-Operating Cash Flow Ratio | 17.77 | 24.33 | 29.64 | 21.86 | 22.19 |
| Price-to-Earnings Growth (PEG) Ratio | 7.43 | 1.07 | -1.38 | 1.52 | 3.15 |
| Enterprise Value Multiple | 15.54 | 17.42 | 18.17 | 15.15 | 21.23 |
| Enterprise Value | 67.16B | 73.59B | 68.63B | 64.53B | 74.74B |
| EV to EBITDA | 15.54 | 17.42 | 18.17 | 15.15 | 21.23 |
| EV to Sales | 3.05 | 3.29 | 3.17 | 2.97 | 4.15 |
| EV to Free Cash Flow | 31.46 | 41.51 | 70.68 | 45.96 | 35.44 |
| EV to Operating Cash Flow | 23.11 | 29.81 | 37.94 | 28.60 | 26.86 |
| Tangible Book Value Per Share | -2.91 | -2.90 | -3.44 | -3.53 | -4.31 |
| Shareholders’ Equity Per Share | 9.46 | 8.15 | 8.08 | 8.83 | 7.29 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.22 | 0.21 | 0.27 | 0.27 |
| Revenue Per Share | 9.84 | 10.02 | 9.68 | 9.67 | 8.18 |
| Net Income Per Share | 0.90 | 0.87 | 0.67 | 0.91 | 0.79 |
| Tax Burden | 0.75 | 0.77 | 0.78 | 0.73 | 0.72 |
| Interest Burden | 0.87 | 0.84 | 0.87 | 0.96 | 0.97 |
| Research & Development to Revenue | 0.08 | 0.09 | 0.09 | 0.08 | 0.09 |
| SG&A to Revenue | 0.16 | 0.15 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.44 | 1.27 | 1.20 | 1.11 | 1.61 |
Currency in EUR
